Literature DB >> 12382203

The copper-iron connection: hereditary aceruloplasminemia.

Thalia Nittis1, Jonathan D Gitlin.   

Abstract

Hereditary aceruloplasminemia is an autosomal recessive disorder of iron homeostasis due to loss-of-function mutations in the ceruloplasmin gene. Affected individuals may present in adulthood with evidence of hepatic iron overload, diabetes, peripheral retinal degeneration, dystonia, dementia, or dysarthria. Laboratory studies demonstrate microcytic anemia, elevated serum ferritin, and a complete absence of serum ceruloplasmin ferroxidase activity. Consistent with the observed neurologic findings, magnetic resonance imaging reveals iron accumulation within the basal ganglia. Histologic studies detect abundant iron in hepatocytes, reticuloendothelial cells of the liver and spleen, beta cells of the pancreas, and astrocytes and neurons throughout the central nervous system. Characterization of this disorder reveals an essential role for ceruloplasmin in determining the rate of iron efflux from cells with mobilizable iron stores and provides new insights into the mechanisms of human iron metabolism. Copyright 2002, Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12382203     DOI: 10.1053/shem.2002.35633

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  14 in total

1.  The Steap proteins are metalloreductases.

Authors:  Robert S Ohgami; Dean R Campagna; Alice McDonald; Mark D Fleming
Journal:  Blood       Date:  2006-04-11       Impact factor: 22.113

Review 2.  Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.

Authors:  Garth J S Cooper
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

3.  Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation.

Authors:  R Mariani; C Arosio; S Pelucchi; M Grisoli; A Piga; P Trombini; A Piperno
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

4.  Copper transport into the secretory pathway is regulated by oxygen in macrophages.

Authors:  Carine White; Taiho Kambe; Yan G Fulcher; Sherri W Sachdev; Ashley I Bush; Kevin Fritsche; Jaekwon Lee; Thomas P Quinn; Michael J Petris
Journal:  J Cell Sci       Date:  2009-04-07       Impact factor: 5.285

5.  FEA1, FEA2, and FRE1, encoding two homologous secreted proteins and a candidate ferrireductase, are expressed coordinately with FOX1 and FTR1 in iron-deficient Chlamydomonas reinhardtii.

Authors:  Michael D Allen; José A del Campo; Janette Kropat; Sabeeha S Merchant
Journal:  Eukaryot Cell       Date:  2007-07-27

Review 6.  The Yin and Yang of copper during infection.

Authors:  Angelique N Besold; Edward M Culbertson; Valeria C Culotta
Journal:  J Biol Inorg Chem       Date:  2016-01-20       Impact factor: 3.358

Review 7.  Inborn errors of metabolism associated with hyperglycaemic ketoacidosis and diabetes mellitus: narrative review.

Authors:  Majid Alfadhel; Amir Babiker
Journal:  Sudan J Paediatr       Date:  2018

8.  Copper supplementation reverses dietary iron overload-induced pathologies in mice.

Authors:  Tao Wang; Ping Xiang; Jung-Heun Ha; Xiaoyu Wang; Caglar Doguer; Shireen R L Flores; Yujian James Kang; James F Collins
Journal:  J Nutr Biochem       Date:  2018-06-04       Impact factor: 6.048

9.  Copper deficiency leads to anemia, duodenal hypoxia, upregulation of HIF-2α and altered expression of iron absorption genes in mice.

Authors:  Pavle Matak; Sara Zumerle; Maria Mastrogiannaki; Souleiman El Balkhi; Stephanie Delga; Jacques R R Mathieu; François Canonne-Hergaux; Joel Poupon; Paul A Sharp; Sophie Vaulont; Carole Peyssonnaux
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

10.  Schizophrenia-like psychosis and aceruloplasminemia.

Authors:  Mark Walterfang; Evrim March; Daniel Varghese; Kathryn Miller; Leonie Simpson; Bruce Tomlinson; Dennis Velakoulis
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.